Hims & Hers Health GAAP EPS of $0.32 beats by $0.27, revenue of $401.6M beats by $18.83M

seekingalpha
2024-11-05
  • Hims & Hers Health press release (NYSE:HIMS): Q3 GAAP EPS of $0.32 beats by $0.27.
  • Revenue of $401.6M (+77.2% Y/Y) beats by $18.83M.
  • Hims & Hers is providing the following guidance:

  • For the fourth quarter 2024, the company expects:

  • Revenue of $465 million to $470 million vs $421.11M consensus

  • Adjusted EBITDA of $50 million to $55 million, reflecting an Adjusted EBITDA margin of 11% to 12%.

  • For the full year 2024, expects:

  • Revenue of $1.460 billion to $1.465 billion vs $1.40B consensus

  • Adjusted EBITDA of $173 million to $178 million, reflecting an Adjusted EBITDA margin of 12%.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10